BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9234377)

  • 1. Phenotypic analysis of retinal leukocyte infiltration during combined cyclosporin A and nasal antigen administration of retinal antigens: delay and inhibition of macrophage and granulocyte infiltration.
    Dick AD; Kreutzer B; Laliotou B; Forrester JV
    Ocul Immunol Inflamm; 1997 Jun; 5(2):129-40. PubMed ID: 9234377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mycophenolate mofetil on nasal mucosal tolerance induction.
    Dick AD; Kreutzer B; Laliotou B; Forrester JV
    Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):835-40. PubMed ID: 9538893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulating phenotype and cytokine production of leucocytic retinal infiltrate in experimental autoimmune uveoretinitis following intranasal tolerance induction with retinal antigens.
    Laliotou B; Dick AD
    Br J Ophthalmol; 1999 Apr; 83(4):478-85. PubMed ID: 10434874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal administration of retinal antigens maintains immunosuppression of uveoretinitis in cyclosporin-A-treated Lewis rats: future treatment of endogenous posterior uveoretinitis?
    Kreutzer B; Laliotou B; Cheng YF; Liversidge J; Forrester JV; Dick AD
    Eye (Lond); 1997; 11 ( Pt 4)():445-52. PubMed ID: 9425406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina.
    Dick AD; McMenamin PG; Körner H; Scallon BJ; Ghrayeb J; Forrester JV; Sedgwick JD
    Eur J Immunol; 1996 May; 26(5):1018-25. PubMed ID: 8647162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal microenvironment controls resident and infiltrating macrophage function during uveoretinitis.
    Robertson MJ; Erwig LP; Liversidge J; Forrester JV; Rees AJ; Dick AD
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2250-7. PubMed ID: 12091424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resident and infiltrating immune cells in the uveal tract in the early and late stages of experimental autoimmune uveoretinitis.
    Butler TL; McMenamin PG
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2195-210. PubMed ID: 8843906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marrow-derived activated macrophages are required during the effector phase of experimental autoimmune uveoretinitis in rats.
    Forrester JV; Huitinga I; Lumsden L; Dijkstra CD
    Curr Eye Res; 1998 Apr; 17(4):426-37. PubMed ID: 9561835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing tumor necrosis factor-alpha activity suppresses activation of infiltrating macrophages in experimental autoimmune uveoretinitis.
    Robertson M; Liversidge J; Forrester JV; Dick AD
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3034-41. PubMed ID: 12824249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resident and infiltrating cells in the rat iris during the early stages of experimental melanin protein-induced uveitis (EMIU).
    McMenamin PG; Crewe J; Kijlstra A
    Ocul Immunol Inflamm; 1997 Dec; 5(4):223-33. PubMed ID: 9455739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of leflunomide on experimental autoimmune uveitis in Lewis rats].
    Fang C; Zhou D; Zhan S; He Y; Lin Z; Huang C; Li J
    Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):754-61. PubMed ID: 26693771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental autoimmune uveoretinitis (EAU)-related tissue damage and angiogenesis is reduced in CCL2⁻/⁻CX₃CR1gfp/gfp mice.
    Zhao J; Chen M; Xu H
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7572-82. PubMed ID: 25342612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recruitment of antigen-nonspecific cells plays a pivotal role in the pathogenesis of a T cell-mediated organ-specific autoimmune disease, experimental autoimmune uveoretinitis.
    Caspi RR; Chan CC; Fujino Y; Najafian F; Grover S; Hansen CT; Wilder RL
    J Neuroimmunol; 1993 Sep; 47(2):177-88. PubMed ID: 8370769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of experimental autoimmune uveitis by retinal photoreceptor antigens coupled to spleen cells.
    Dua HS; Gregerson DS; Donoso LA
    Cell Immunol; 1992 Feb; 139(2):292-305. PubMed ID: 1733504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.
    Wildner G; Thurau SR
    Eur J Immunol; 1995 May; 25(5):1292-7. PubMed ID: 7774632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of cyclosporins A and G on functional activation of a T-helper-lymphocyte line mediating experimental autoimmune uveoretinitis.
    Caspi RR; McAllister CG; Gery I; Nussenblatt RB
    Cell Immunol; 1988 May; 113(2):350-60. PubMed ID: 2965988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interphotoreceptor retinoid binding protein is a potent tolerogen in Lewis rat: suppression of experimental autoimmune uveoretinitis is retinal antigen specific.
    Laliotou B; Liversidge J; Forrester JV; Dick AD
    Br J Ophthalmol; 1997 Jan; 81(1):61-7. PubMed ID: 9135411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastructural pathology of experimental autoimmune uveitis. Quantitative evidence of activation and possible high endothelial venule-like changes in retinal vascular endothelium.
    McMenamin PG; Forrester JV; Steptoe RJ; Dua HS
    Lab Invest; 1992 Jul; 67(1):42-55. PubMed ID: 1625447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leflunomide: inhibition of S-antigen induced autoimmune uveitis in Lewis rats.
    Robertson SM; Lang LS
    Agents Actions; 1994 Oct; 42(3-4):167-72. PubMed ID: 7879705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of retinal S-antigen-specific monoclonal antibody therapy on experimental autoimmune uveoretinitis (EAU) and experimental autoimmune pinealitis (EAP).
    Dua HS; Sewell HF; Forrester JV
    Clin Exp Immunol; 1989 Jan; 75(1):100-5. PubMed ID: 2784726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.